1-12 of 12
Guangzhou Han
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6020: GPC3-targeted radiopharmaceutical therapy for neuroendocrine prostate cancer

Renee Clift, Fanching Lin, Katrina Salvador, Matt Guest, Daniel Kim, Guangzhou Han, Gary Li
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6020.
https://doi.org/10.1158/1538-7445.AM2024-6020
Published: 22 March 2024
View article titled, Abstract 6020: GPC3-targeted radiopharmaceutical therapy for neuroendocrine prostate cancer
Journal Articles

Abstract 5042: Anti-tumor activity of RYZ101 (Ac-225 DOTATATE) in somatostatin receptor-expressing preclinical models of small-cell lung cancer

Guangzhou Han, Eunmi Hwang, Fanching Lin, Renee Clift, Daniel Kim, Eric Bischoff, Susan Moran, Gary Li
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5042.
https://doi.org/10.1158/1538-7445.AM2023-5042
Published: 04 April 2023
View article titled, Abstract 5042: Anti-tumor activity of RYZ101 (Ac-225 DOTATATE) in somatostatin receptor-expressing preclinical models of small-cell lung cancer
Journal Articles

A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma

Eli M. Wallace, James P. Rizzi, Guangzhou Han, Paul M. Wehn, Zhaodan Cao, Xinlin Du, Tzuling Cheng, Robert M. Czerwinski, Darryl D. Dixon, Barry S. Goggin, Jonas A. Grina, Megan M. Halfmann, Melissa A. Maddie, Sarah R. Olive, Stephen T. Schlachter, Huiling Tan, Bin Wang, Keshi Wang, Shanhai Xie, Rui Xu, Hanbiao Yang, John A. Josey
Journal: Cancer Research
Series: Author Choice
Cancer Res (2016) 76 (18): 5491–5500.
https://doi.org/10.1158/0008-5472.CAN-16-0473
Published: 15 September 2016
View article titled, A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Open the PDF for A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 4022: PT2385, a novel HIF-2α antagonist, combines with checkpoint inhibitor antibodies to inhibit tumor growth in preclinical models by modulating myeloid cells and enhancing T cell infiltration

Guangzhou Han, Christina Stevens, Zhaodan Cao, Shanhai Xie, Melissa Maddie, Barry Goggin, Eli Wallace, John Josey, Tai W. Wong
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4022.
https://doi.org/10.1158/1538-7445.AM2016-4022
Published: 15 July 2016
View article titled, Abstract 4022: PT2385, a novel HIF-2α antagonist, combines with checkpoint inhibitor antibodies to inhibit tumor growth in preclinical models by modulating myeloid cells and enhancing T cell infiltration
Journal Articles

Abstract DDT01-01: PT2385: First-in-class HIF-2α antagonist for the treatment of renal cell carcinoma

Eli M. Wallace, Zhaodan Cao, Tzuling Cheng, Robert Czerwinski, Darryl D. Dixon, Xinlin Du, Barry Goggin, Jonas Grina, Megan Halfmann, Guangzhou Han, Heli Huang, John A. Josey, Melissa A. Maddie, Sarah Olive, James Rizzi, Stephen T. Schlachter, Hui-Ling Tan, Bin Wang, Keshi Wang, Paul M. Wehn, Shanhai Xie, Rui Xu, Hanbiao Yang
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): DDT01-01.
https://doi.org/10.1158/1538-7445.AM2015-DDT01-01
Published: 01 August 2015
View article titled, Abstract DDT01-01: PT2385: First-in-class HIF-2α antagonist for the treatment of renal cell carcinoma
Journal Articles

Abstract 3485: Inhibition of Notch signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells

Ping Wei, Ming Qiu, Ivy Jiang, Christopher Carroll, Guangzhou Han, Isha Rymer, Eugenia Kraynov, Aidong Wu, Stephane Thibault, Donna Stone, Yijie Gao, Susan Sofia, Jorge Gallo, Janet White, Gary Li, Jennifer Yang, Gerrit Los
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3485.
https://doi.org/10.1158/1538-7445.AM2012-3485
Published: 15 April 2012
View article titled, Abstract 3485: Inhibition of Notch signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells
Journal Articles

Role of Vitamin D Receptor in the Antiproliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis In vivo

Ivy Chung, Guangzhou Han, Mukund Seshadri, Bryan M. Gillard, Wei-dong Yu, Barbara A. Foster, Donald L. Trump, Candace S. Johnson
Journal: Cancer Research
Cancer Res (2009) 69 (3): 967–975.
https://doi.org/10.1158/0008-5472.CAN-08-2307
Published: 29 January 2009
View article titled, Role of Vitamin D Receptor in the Antiproliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis <em>In vivo</em>
Open the PDF for Role of Vitamin D Receptor in the Antiproliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis <em>In vivo</em> in another window
Journal Articles

Androgen receptor, co-factors and prostate cancer

Renee S. Chmelar, Guangzhou Han, Norman M. Greenberg
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 221–222.
Published: 15 April 2006
View article titled, Androgen receptor, co-factors and prostate cancer
Journal Articles

Expression of c-Jun oncoprotein in androgen depletion independent prostate cancer

Guangzhou Han, Xiaoqing Yu, Brent W. Sutherland, Norman M. Greenberg
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 23.
Published: 15 April 2006
View article titled, Expression of c-Jun oncoprotein in androgen depletion independent prostate cancer
Journal Articles

Identification and validation of androgen receptor direct targets in prostate cancer by chromatin immunoprecipitation

Guangzhou Han, Norman M. Greenberg
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 749.
Published: 01 May 2005
View article titled, Identification and validation of androgen receptor direct targets in prostate cancer by chromatin immunoprecipitation
Journal Articles

Specific mutations in the androgen receptor can cause rapid development of prostatic intraepithelial neoplasia that progresses to invasive and metastatic prostate cancer.

Guangzhou Han, Norman M. Greenberg
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1317.
Published: 01 April 2004
View article titled, Specific mutations in the androgen receptor can cause rapid development of prostatic intraepithelial neoplasia that progresses to invasive and metastatic prostate cancer.
Journal Articles

Specific mutations in the androgen receptor can cause rapid development of prostatic intraepithelial neoplasia that progresses to invasive and metastatic prostate cancer

Guangzhou Han, Scott F. Winter, Caroline Castile, Xiaoqing Yu, Francesco J. Demayo, Norman M. Greenberg
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1284.
Published: 01 April 2004
View article titled, Specific mutations in the androgen receptor can cause rapid development of prostatic intraepithelial neoplasia that progresses to invasive and metastatic prostate cancer